Cardia Inc.

Cardia develops, manufactures and markets state-of-the-art transcatheter septal occluders with the intent to help people with congenital cardiac defects lead happy and healthy lives. Ultrasept, our latest family of products, serves as our 7th generation of septal closure devices. The dual articulating sails allow for easy deployment of the devices and create a super low profile within the atria. Ultrasept devices boast a simple, hands-free loading feature and are fully retrievable before and after release. Ultrasept products include double-round devices for the percutaneous closure of both PFO’s (Patent Foramen Ovale) and ASD’s (Atrial Septal Defect). A septal occluder is a cardiac implant that fixes a cardiac defect commonly referred to as a “hole in the heart." Our devices are delivered through a catheter by an interventional cardiologist and only take about 30 minutes to implant. Many patients are admitted to the hospital in the morning and return home that afternoon or the next day without the lengthy recovery periods often needed after open-heart surgery. FDA Disclaimer: http://cardia.com/FdaDisclaimer.html